| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/02/2000 | WO2000010578A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
| 03/02/2000 | WO1999063093A3 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 03/02/2000 | WO1999061620A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 03/02/2000 | WO1999061614A3 Human socs proteins |
| 03/02/2000 | WO1999058558A3 Cell signaling proteins |
| 03/02/2000 | WO1999057149A3 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 03/02/2000 | WO1999055367A9 INTERNALIZING ErbB2 ANTIBODIES |
| 03/02/2000 | WO1999054465A3 Gene encoding syntaxin interacting protein |
| 03/02/2000 | WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 03/02/2000 | WO1999045031A3 Cd147 binding molecules as therapeutics |
| 03/02/2000 | WO1999042596A3 Phosphodiesterase 10 |
| 03/02/2000 | WO1999036535A9 Apo-2 ligand |
| 03/02/2000 | WO1999024578A3 Neisserial antigens |
| 03/02/2000 | DE19839736A1 Humane monoklonale Antikörper gegen Inselzellantigen IA-2 Human monoclonal antibodies against islet cell antigen IA-2 |
| 03/02/2000 | CA2341637A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 03/02/2000 | CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 03/02/2000 | CA2340884A1 49 human secreted proteins |
| 03/02/2000 | CA2340787A1 An anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
| 03/02/2000 | CA2340785A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 03/02/2000 | CA2340692A1 Immunogenic .beta.-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide |
| 03/02/2000 | CA2340466A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 03/02/2000 | CA2340457A1 14400 receptor, a g-protein coupled receptor |
| 03/02/2000 | CA2340334A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
| 03/02/2000 | CA2340318A1 Monoclonal antibody inhibiting the liberation of cell atp and hybridomas producing the monoclonal antibody |
| 03/02/2000 | CA2340307A1 Artiodactyl epimorphine |
| 03/02/2000 | CA2340305A1 Hiv suppressor factor derived from scrub typhus |
| 03/02/2000 | CA2340277A1 Human rna-associated proteins |
| 03/02/2000 | CA2339968A1 Dcr5, a bmp-binding protein, and applications thereof |
| 03/02/2000 | CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
| 03/02/2000 | CA2339860A1 Human cell signaling proteins (csig) |
| 03/02/2000 | CA2339036A1 Tpl-2/cot kinase and methods of use |
| 03/01/2000 | EP0982591A2 Imprints formed using functionally complemetary monomers |
| 03/01/2000 | EP0982400A1 Human glycine transporter |
| 03/01/2000 | EP0982318A2 Enchanced phosphorylation of P53 by ATM in response to DNA damage |
| 03/01/2000 | EP0982036A1 Modulation of Beta2 -integrin-mediated cell adhesion |
| 03/01/2000 | EP0981748A1 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 03/01/2000 | EP0981651A1 Detection of retroviral subtypes based upon envelope specific sequences |
| 03/01/2000 | EP0981649A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
| 03/01/2000 | EP0981642A1 Kappa b kinase, subunits thereof, and methods of using same |
| 03/01/2000 | EP0981637A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 03/01/2000 | EP0981629A1 Forms of prostate specific antigen and methods for their detection |
| 03/01/2000 | EP0981627A1 Purified telomerase |
| 03/01/2000 | EP0981625A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES |
| 03/01/2000 | EP0981623A1 Gene encoding for systemic acquired resistance in arabidopsis |
| 03/01/2000 | EP0981619A1 T1/st2-receptor ligand iii |
| 03/01/2000 | EP0981618A1 Apo-2 RECEPTOR |
| 03/01/2000 | EP0981615A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 03/01/2000 | EP0981611A1 Polynucleotides encoding proexendin, and methods and uses thereof |
| 03/01/2000 | EP0981610A2 Compositions for treatment of disorders involving programmed cell death |
| 03/01/2000 | EP0981550A1 Methods for eosinophil depletion and compositions therefor |
| 03/01/2000 | EP0981549A1 A method for the improvement of neuronal regeneration |
| 03/01/2000 | EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
| 03/01/2000 | EP0981547A1 Tumor-associated antigen |
| 03/01/2000 | EP0981546A1 Protein smi on hematopoietic stem cells |
| 03/01/2000 | EP0981541A1 Psca: prostate stem cell antigen |
| 03/01/2000 | EP0981369A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
| 03/01/2000 | EP0981364A1 Method and compositions for treating hyperlipidemia and other conditions |
| 03/01/2000 | EP0702564B1 Novel attenuated pseudomonas aeruginosa strains |
| 03/01/2000 | EP0666760B1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
| 02/29/2000 | US6031156 Heterologous gene expression utilizing plant asparagine synthetase promoters |
| 02/29/2000 | US6031150 Genome with homozygous disruption of gene by selectable marker; for studying non-insulin dependent diabetes mellitus and persistent hyperinsulinemic hypoglycemia of infancy |
| 02/29/2000 | US6031090 Molecular cloning of a 7TM receptor (GPR31A) |
| 02/29/2000 | US6031079 Amino acid sequence; for screening modulators |
| 02/29/2000 | US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics |
| 02/29/2000 | US6030947 Treating p150,95-mediated inflammation which comprises administering an anti-inflammatory agent comprising alpha-subunit of human p150,95 in association with beta-subunit of member of lfa-1 family of receptor molecules |
| 02/29/2000 | US6030945 Apo-2 ligand |
| 02/29/2000 | US6030831 Tie ligand homologues |
| 02/29/2000 | US6030830 Nucleotide sequences which are bridging templates for recombination of genomic dna resulting in immunoglobulin isotype switching; for treatment of allergies |
| 02/29/2000 | US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030811 Polynucleotides encoding a human mystrophin clone, HSABH01 |
| 02/29/2000 | US6030808 Nucleic acids encoding receptor recognition factor stat 3 and methods of use thereof |
| 02/29/2000 | US6030797 Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof |
| 02/29/2000 | US6030796 Complementary dna sequence which codes for a chimeric antibody directed to an extracellular epitope of the human trans-plasma membrane p-glycoprotein to strongly suppress drug efflux and increase cytotoxicity of anticancer agents |
| 02/29/2000 | US6030792 Quantitative immunoassay using capture and detection antibodies against specific amino acid sequences of collagen fragments resulting from collagenase cleavage of type ii collagen |
| 02/29/2000 | US6030790 Kit for detecting active human parathyroid hormone including two sets of antibodies or antibody fragments; for diagnosis |
| 02/29/2000 | US6030772 Neutralizing antibodies against HIV infection |
| 02/29/2000 | US6030769 Strains of human immunodeficiency virus; for use as sensitive diagnositic agents and immunogenic compositions |
| 02/29/2000 | US6030619 Molecular mimetics of meningococcal B epitopes |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030616 Hepatitis B escape mutant specific binding molecules |
| 02/29/2000 | US6030615 Combination method for treating diseases caused by cytokine-mediated toxicity |
| 02/29/2000 | US6030614 Passing plasma of human recipient over column to effect binding of anti-human immunoglobulins antibodies to immunoglobulin in recipient's blood and recovering an effluent, reinfusing effluent |
| 02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
| 02/29/2000 | CA2077753C Purified gp120 composition retaining natural conformation |
| 02/29/2000 | CA2033347C Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 02/29/2000 | CA1340914C Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc |
| 02/28/2000 | CA2249037A1 Novel compounds |
| 02/26/2000 | CA2280675A1 Enhanced phosphorylation of p53 by atm in response to dna damage |
| 02/24/2000 | WO2000009754A2 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
| 02/24/2000 | WO2000009739A1 Monoclonal antibody against canine trypsin |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 02/24/2000 | WO2000009725A2 Method for recovering proteins from the interstitial fluid of plant tissues |
| 02/24/2000 | WO2000009715A1 Modulation of polypeptide display on modified filamentous phage |
| 02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 02/24/2000 | WO2000009710A2 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists |
| 02/24/2000 | WO2000009709A2 Proteases and associated proteins |
| 02/24/2000 | WO2000009695A2 Drug targets in candida albicans |
| 02/24/2000 | WO2000009693A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |